Abstract
Although 3 hyaluronic acid preparations are commercially available for treating osteoarthritis, there is still considerable uncertainty regarding the optimal use of this therapy. A discussion of trials conducted to date, and the results of 2 new placebo-controlled studies, were discussed at a Seikagaku-sponsored satellite symposium during the 8th Asia-Pacific League Against Rheumatism Congress [Melbourne, Australia; April 1996].
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
